image
Consumer Defensive - Packaged Foods - NYSE - US
$ 24.7
-3.06 %
$ 467 M
Market Cap
11.28
P/E
1. INTRINSIC VALUE

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one USNA stock under the worst case scenario is HIDDEN Compared to the current market price of 24.7 USD, USANA Health Sciences, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one USNA stock under the base case scenario is HIDDEN Compared to the current market price of 24.7 USD, USANA Health Sciences, Inc. is HIDDEN

This DCF valuation model was last updated on Apr, 8, 2025.

The intrinsic value of one USNA stock under the best case scenario is HIDDEN Compared to the current market price of 24.7 USD, USANA Health Sciences, Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart USNA

image
$42.0$42.0$40.0$40.0$38.0$38.0$36.0$36.0$34.0$34.0$32.0$32.0$30.0$30.0$28.0$28.0$26.0$26.0$24.0$24.015 Oct15 OctNov '24Nov '2415 Nov15 NovDec '24Dec '2415 Dec15 DecJan '25Jan '2515 Jan15 JanFeb '25Feb '2515 Feb15 FebMar '25Mar '2515 Mar15 MarApr '25Apr '25
FINANCIALS
855 M REVENUE
-7.22%
66.3 M OPERATING INCOME
-28.74%
42.1 M NET INCOME
-34.06%
61 M OPERATING CASH FLOW
-13.66%
-213 M INVESTING CASH FLOW
-1679.46%
9.55 M FINANCING CASH FLOW
167.10%
214 M REVENUE
6.69%
8.21 M OPERATING INCOME
-47.38%
4.48 M NET INCOME
-57.73%
5.78 M OPERATING CASH FLOW
-80.41%
-205 M INVESTING CASH FLOW
-8674.08%
22.9 M FINANCING CASH FLOW
29497.44%
Balance Sheet USANA Health Sciences, Inc.
image
Current Assets 279 M
Cash & Short-Term Investments 182 M
Receivables 0
Other Current Assets 97.4 M
Non-Current Assets 469 M
Long-Term Investments 0
PP&E 94.6 M
Other Non-Current Assets 374 M
24.29 %13.02 %12.64 %50.05 %Total Assets$748.2m
Current Liabilities 140 M
Accounts Payable 12 M
Short-Term Debt 23 M
Other Current Liabilities 105 M
Non-Current Liabilities 22.2 M
Long-Term Debt 0
Other Non-Current Liabilities 22.2 M
7.40 %14.21 %64.65 %13.74 %Total Liabilities$161.9m
EFFICIENCY
Earnings Waterfall USANA Health Sciences, Inc.
image
Revenue 855 M
Cost Of Revenue 161 M
Gross Profit 693 M
Operating Expenses 627 M
Operating Income 66.3 M
Other Expenses 24.3 M
Net Income 42.1 M
900m900m800m800m700m700m600m600m500m500m400m400m300m300m200m200m100m100m00855m(161m)693m(627m)66m(24m)42mRevenueRevenueCost Of RevenueCost Of RevenueGross ProfitGross ProfitOperating ExpensesOperating ExpensesOperating IncomeOperating IncomeOther ExpensesOther ExpensesNet IncomeNet Income
RATIOS
81.13% GROSS MARGIN
81.13%
7.76% OPERATING MARGIN
7.76%
4.92% NET MARGIN
4.92%
7.90% ROE
7.90%
5.62% ROA
5.62%
5.78% ROIC
5.78%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis USANA Health Sciences, Inc.
image
160m160m140m140m120m120m100m100m80m80m60m60m40m40m20m20m00201720172018201820192019202020202021202120222022202320232024202420252025
Net Income 42.1 M
Depreciation & Amortization 14.5 M
Capital Expenditures -10.1 M
Stock-Based Compensation 14.6 M
Change in Working Capital 0
Others -13 M
Free Cash Flow 50.9 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets USANA Health Sciences, Inc.
image
Wall Street analysts predict an average 1-year price target for USNA of $39.7 , with forecasts ranging from a low of $35 to a high of $46 .
USNA Lowest Price Target Wall Street Target
35 USD 41.70%
USNA Average Price Target Wall Street Target
39.7 USD 60.59%
USNA Highest Price Target Wall Street Target
46 USD 86.23%
Price
Max Price Target
Min Price Target
Average Price Target
5050454540403535303025252020May '24May '24Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
4. DIVIDEND ANALYSIS
5. COMPETITION
slide 2 of 9
6. Ownership
Insider Ownership USANA Health Sciences, Inc.
image
Sold
0-3 MONTHS
654 K USD 7
3-6 MONTHS
25.5 K USD 1
6-9 MONTHS
312 K USD 3
9-12 MONTHS
1.46 M USD 5
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
7. News
USANA Exec. Chairman Kevin Guest Celebrates Guitar Month, Stress Awareness Month for Harmony SALT LAKE CITY , April 1, 2025 /PRNewswire/ -- USANA Health Sciences (NYSE: USNA) Executive Chairman Kevin Guest marks April's convergence of International Guitar Month and Stress Awareness Month, as a perfect pairing that celebrates the healing power of music for mental well-being. While music has long been heralded as a universal remedy, the guitar offers far more than just melodies. prnewswire.com - 2 weeks ago
USANA Exec. Chairman Kevin Guest Invites All to Celebrate March's Listening Awareness Month SALT LAKE CITY , March 3, 2025 /PRNewswire/ -- USANA Executive Chairman Kevin Guest announces the company's enthusiastic support for March's Listening Awareness Month, encouraging individuals everywhere to explore and celebrate the transformational power of listening. Through heartfelt personal stories and actionable insights, Guest emphasizes how active listening can strengthen personal and professional relationships and foster deeper understanding. prnewswire.com - 1 month ago
USANA Health Sciences, Inc. (USNA) Q4 2024 Earnings Conference Call Transcript USANA Health Sciences, Inc. (NYSE:USNA ) Q4 2024 Earnings Conference Call February 26, 2025 11:00 AM ET Company Participants Andrew Masuda - IR Jim Brown - President and CEO Brent Neidig - Chief Commercial Officer Doug Hekking - CFO Walter Noot - COO Conference Call Participants Anthony Lebiedzinski - Sidoti Christina Xue - D.A. Davidson Ivan Feinseth - Tigress Financial Partners Doug Lane - Water Tower Research Operator Greetings, and welcome to the USANA Health Sciences' Fourth Quarter Conference Call. seekingalpha.com - 1 month ago
USANA Health Sciences (USNA) Surpasses Q4 Earnings and Revenue Estimates USANA Health Sciences (USNA) came out with quarterly earnings of $0.64 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.87 per share a year ago. zacks.com - 1 month ago
Should Value Investors Buy USANA Health Sciences (USNA) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 1 month ago
5 Low Price-to-Book Stocks Worthy of Value Investors' Attention The P/B ratio helps to identify low-priced stocks with high growth prospects. GM, KT, GBX, USNA and ENS are some such stocks. zacks.com - 1 month ago
USNA or STVN: Which Is the Better Value Stock Right Now? Investors interested in Medical - Drugs stocks are likely familiar with USANA Health Sciences (USNA) and Stevanato Group (STVN). But which of these two stocks presents investors with the better value opportunity right now? zacks.com - 2 months ago
5 Promising Price-to-Book Value Stocks to Buy in February The P/B ratio helps to identify low-priced stocks with high growth prospects. GM, USNA, GBX, KT and ENS are some such stocks. zacks.com - 2 months ago
Kevin Guest Encourages Confidence, Personal Growth for International Boost Self-Esteem Month SALT LAKE CITY , Feb. 3, 2025 /PRNewswire/ -- Throughout February, Kevin Guest invites individuals everywhere to celebrate International Boost Self-Esteem Month—a time dedicated to building confidence, fostering self-worth and inspiring personal empowerment. Because self-esteem is the cornerstone of a healthy, fulfilling life—shaping relationships, fueling careers and influencing overall well-being—now is the ideal time for individuals to prioritize themselves and take meaningful steps toward becoming more confident and empowered. prnewswire.com - 2 months ago
USNA vs. STVN: Which Stock Is the Better Value Option? Investors looking for stocks in the Medical - Drugs sector might want to consider either USANA Health Sciences (USNA) or Stevanato Group (STVN). But which of these two stocks offers value investors a better bang for their buck right now? zacks.com - 2 months ago
Are Investors Undervaluing USANA Health Sciences (USNA) Right Now? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. zacks.com - 2 months ago
USANA Appoints New Chief Scientific Officer Dr. Kathryn Armstrong brings 17 years of scientific expertise to the company SALT LAKE CITY , Jan. 22, 2025 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in cellular nutrition, is proud to announce that Dr. Kathryn Armstrong, Ph.D., will be assuming the role of chief scientific officer at the company. prnewswire.com - 2 months ago
8. Profile Summary

USANA Health Sciences, Inc. USNA

image
COUNTRY US
INDUSTRY Packaged Foods
MARKET CAP $ 467 M
Dividend Yield 0.00%
Description USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Contact 3838 West Parkway Boulevard, Salt Lake City, UT, 84120 https://www.usana.com
IPO Date April 4, 1994
Employees 1700
Officers Mr. David Mulham Chief Sales Officer Peter Benedict Chief Information Officer Mr. Patrique Richards Executive Director of Investor Relations & Business Development Mr. Paul A. Jones C.M.A. Chief People Officer Mr. Walter Noot Chief Operating Officer Mr. P. Joshua Foukas J.D. Chief Legal Officer, General Counsel & Corporate Secretary Dr. Myron W. Wentz Ph.D. Founder & Chairman Emeritus Mr. G. Douglas Hekking Chief Financial Officer Mr. Jim Brown Chief Executive Officer & President Dr. John Cuomo Executive Director of Product Development & Technology